An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia
An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia
Active, not recruiting · NCT04053803 · Registry updated 2022-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Active, not recruiting | Phase 2 | 2022-03-04 | NCT04053803 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Imara, Inc. | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor Scott & White Medical Center - Temple | Temple | United States | 13 |
| Bristol Haematology and Oncology Centre | Bristol | United Kingdom | 9 |
| Foundation for Sickle Cell Disease Research | Hollywood | United States | 1 |
| Guy's and St Thomas Hospital CRF | London | United Kingdom | 1 |
| Royal London Hospital | London | United Kingdom | 10 |
| University College London Hospital NHS Foundation Trust | London | United Kingdom | 2 |
| University of Connecticut Health Center | Farmington | United States | 18 |